350
Participants
Start Date
January 31, 2003
Primary Completion Date
October 31, 2004
Study Completion Date
October 31, 2004
docetaxel
paclitaxel poliglumex
Queens Medical Associates, PC, Fresh Meadows
Pennsylvania Oncology Hematology Associates, Philadelphia
Danville Hematology and Oncology, Incorporated, Danville
Virginia Oncology Care P.C., Richlands
Piedmont Oncology Specialist, II, PLLC, Monroe
Santee Hematology Oncology, Sumter
Charleston Hematology-Oncology, P.A., Charleston
Florida Oncology Associates, Jacksonville
Northwest Oncology and Hematology Associates, Coral Springs
Hematology Oncology Associates of theTreasure Coast - Port St. Lucie, Port Saint Lucie
Clinical Research Consultants, Incorporated, Hoover
Family Cancer Center, Collierville
Kentucky Cancer Clinic, Pikeville
Western Kentucky Hematology/Oncology Group, Paducah
Gabrail Cancer Center - Canton Office, Canton
Odyssey Research Services, Bismarck
Gross Point Medical Center, Skokie
Saint Joseph Oncology, Incorporated, Saint Joseph
Highlands Oncology Group - Springdale, Springdale
Richardson
Southwest Regional Cancer Center, Austin
Arizona Clinical Research Center, Tucson
New Mexico Oncology-Hematology Consultants, Limited, Albuquerque
Las Vegas Cancer Center, Las Vegas
California Hematology/Oncology Medical Group, Torrance
Synergy Hematology/Oncology Medical Associates, Encino
Pacific Cancer Medical Center, Incorporated, Anaheim
Western Washington Medical Group, Everett
California Cancer Care, Inc., Greenbrae
Suburban Hematology-Oncology, Snellville
Montana Cancer Specialists, Missoula
Howell Township
Morristown Memorial Hospital, Morristown
Ireland Cancer Center, Cleveland
Tri County Oncology Associates, Rock Hill
Lead Sponsor
CTI BioPharma
INDUSTRY